2030 Drugs Pharma Companies 
Vial
FEBRUARY 15, 2024
over the forecast period (2022-2030). Role of CROs CROs are third-party organizations that offer support and resources to pharmaceutical, biotech, and medical device companies, as well as research institutions, universities, and government organizations—the so-called sponsors—for their research.
Drug Target Review
OCTOBER 1, 2024
Considering the Italian landscape, for example, it is my opinion that resources allocated by the National Recovery and Resilience Plan (PNRR) for gender equality represent a unique opportunity to aspire to achieve the sustainable development objectives set out in the 2030 Agenda.
Expert insights. Personalized for you.
52 
Let's personalize your content